Saturated fatty acid (SFA) status and SFA intake exhibit different relations with serum total cholesterol and lipoprotein cholesterol: A mechanistic explanation centered around lifestyle-induced low-grade inflammation

Journal of Nutritional Biochemistry

Volumn 25, Issue 3, 2014, Pages 304-312

  Ruiz Núñez, Begoña ^a   Kuipers, Remko S ^a   Luxwolda, Martine F ^a   De Graaf, Deti J ^a   Breeuwsma, Benjamin B ^a   Dijck Brouwer, D A Janneke ^a   Muskiet, Frits A J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Cholesterol; Coronary artery disease; Fatty acid intake; Fatty acid status; Polyunsaturated fatty acids; Saturated fatty acids

Indexed keywords

CHOLESTEROL; CORONARY ARTERY DISEASE; FATTY ACID INTAKE; FATTY ACID STATUS; POLYUNSATURATED FATTY ACIDS; SATURATED FATTY ACIDS;

ADULT; CHOLESTEROL; FATTY ACIDS; FEMALE; HUMANS; INFLAMMATION; LIFE STYLE; LIPOPROTEINS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84893569375     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2013.11.004     Document Type: Article

References (79)

1. Willett W.C. Dietary fats and coronary heart disease. J Intern Med 2012, 272:13-24.
2. Micha R., Mozaffarian D. Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: a fresh look at the evidence. Lipids 2010, 45:893-905.
3. CBO 2006. Cardiovasculair risicomanagement 2006. 2010.
4. Stampfer M.J., Sacks F.M., Salvini S., Willett W.C., Hennekens C.H. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med 1991, 325:373-381.
5. Ravnskov U. A hypothesis out-of-date. The diet-heart idea. J Clin Epidemiol 2002, 55:1057-1063.
6. Hoenselaar R. Saturated fat and cardiovascular disease: the discrepancy between the scientific literature and dietary advice. Nutrition 2012, 28:118-123.
7. Huth P., Park K. Influence of dairy product and milk fat consumption on cardiovascular disease risk: a review of the evidence. Adv Nutr 2012, 3:266-285.
8. Pfeuffer M., Schrezenmeir J. Bioactive substances in milk with properties decreasing risk of cardiovascular diseases. Br J Nutr 2000, 84(Suppl 1):S155-S159.
9. Micha R., Wallace S., Mozaffarian D. Red and processed meat consumption and risk of incident coronary heart disease, stroke, and diabetes mellitus: a systematic review and meta-analysis. Circulation 2010, 121:2271-2283.
10. Mente A., de Koning L., Shannon H., Anand S. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med 2009, 169:659-669.
11. Siri Tarino P., Sun Q., Hu F., Krauss R. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr 2010, 91:535-546.
12. Scarborough P., Rayner M., van Dis I., Norum K. Meta-analysis of effect of saturated fat intake on cardiovascular disease: overadjustment obscures true associations. Am J Clin Nutr 2010, 92:458-459.
13. Egger G., Dixon J. Non-nutrient causes of low-grade, systemic inflammation: support for a 'canary in the mineshaft' view of obesity in chronic disease. Obes Rev 2011, 12:339-345.
14. Ruiz-Núñez B., Pruimboom L., Dijck-Brouwer D.A.J., Muskiet F.A.J. Lifestyle and nutritional imbalances associated with Western diseases: causes and consequences of chronic systemic low grade inflammation in an evolutionary context. J Nutr Biochem 2013, 24:1183-1201.
15. Harris W.S., Mozaffarian D., Rimm E., Kris-Etherton P., Rudel L.L., Appel L.J., et al. Omega-6 fatty acids and risk for cardiovascular disease. Circulation 2009, 119:902-907.
16. Ramsden C.E., Hibbeln J.R., Majchrzak S.F., Davis J.M. n-6 fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: a meta-analysis of randomised controlled trials. Br J Nutr 2010, 104:1586-1600.
17. Ramsden C., Zamora D., Leelarthaepin B., Majchrzak Hong S., Faurot K., Suchindran C., et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ Br Med J 2013, 346:e8707.
18. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999, 340:115-126.
19. Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol 2012, 32:2045-2051.
20. Vaughan C.J., Murphy M.B., Buckley B.M. Statins do more than just lower cholesterol. Lancet 1996, 348:1079-1082.
21. Ridker P. Statin therapy for low-LDL, high-hsCRP patients: from JUPITER to CORONA. Clin Chem 2010, 56:505-507.
22. Barter P., Caulfield M., Eriksson M., Grundy S., Kastelein J.J.P., Komajda M., et al. Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med 2007, 357:2109-2122.
23. Schwartz G., Olsson A., Abt M., Ballantyne C., Barter P., Brumm J., et al. Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med 2012, 367:2089-2099.
24. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
25. Khovidhunkit W., Kim M., Memon R.A., Shigenaga J.K., Moser A.H., Feingold K.R., et al. Thematic review series: the pathogenesis of atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the host. J Lipid Res 2004, 45:1169-1196.
26. Luxwolda M.F., Kuipers R.S., Kema I.P., Janneke Dijck-Brouwer D.A., Muskiet F.A. Traditionally living populations in East Africa have a mean serum 25-hydroxyvitamin D concentration of 115 nmol/l. Br J Nutr 2012, 1-5.
27. van Rossum C, Fransen HP., Verkaik-Kloosterman J., Buurma-Rethans E, Ocké MC. Dutch national food consumption survey 2007-2010. Diet of children and adults aged 7 to 69 years. 2011;RIVM Report 350050006.
28. Verkaik Kloosterman J., van 't Veer J., Ocké M. Reduction of salt: will iodine intake remain adequate in the Netherlands?. Br J Nutr 2010, 104:1712-1718.
29. Muskiet F.A., van Doormaal J.J., Martini I.A., Wolthers B.G., van der Slik W. Capillary gas chromatographic profiling of total long-chain fatty acids and cholesterol in biological materials. J Chromatogr 1983, 278:231-244.
30. Hoving E.B., Jansen G., Volmer M., Van Doormaal J.J., Muskiet F.A. Profiling of plasma cholesterol ester and triglyceride fatty acids as their methyl esters by capillary gas chromatography, preceded by a rapid aminopropyl-silica column chromatographic separation of lipid classes. J Chromatogr 1988, 434:395-409.
31. Mensink R.P., Zock P.L., Kester A.D., Katan M.B. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 2003, 77:1146-1155.
32. Clarke R., Frost C., Collins R., Appleby P., Peto R. Dietary lipids and blood cholesterol: quantitative meta-analysis of metabolic ward studies. BMJ 1997, 314:112-117.
33. Kris-Etherton P.M., Yu S. Individual fatty acid effects on plasma lipids and lipoproteins: human studies. Am J Clin Nutr 1997, 65:1628S-1644S.
34. Hu F.B., Manson J.E., Willett W.C. Types of dietary fat and risk of coronary heart disease: a critical review. J Am Coll Nutr 2001, 20:5-19.
35. Ghafoorunissa Impact of quality of dietary fat on serum cholesterol and coronary heart disease: focus on plant sterols and other non-glyceride components. Natl Med J India 2009, 22:126-132.
36. Hegsted D.M., Ausman L.M., Johnson J.A., Dallal G.E. Dietary fat and serum lipids: an evaluation of the experimental data. Am J Clin Nutr 1993, 57:875-883.
37. Chan J.K., Bruce V.M., McDonald B.E. Dietary alpha-linolenic acid is as effective as oleic acid and linoleic acid in lowering blood cholesterol in normolipidemic men. Am J Clin Nutr 1991, 53:1230-1234.
38. Shepherd J., Packard C.J., Patsch J.R., Gotto A.M., Taunton O.D. Effects of dietary polyunsaturated and saturated fat on the properties of high density lipoproteins and the metabolism of apolipoprotein A-I. J Clin Invest 1978, 61:1582-1592.
39. Harris W.S. N-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 1997, 65:1645S-1654S.
40. Nelson G.J., Schmidt P.C., Bartolini G., Kelley D.S., Phinney S.D., Kyle D., et al. The effect of dietary arachidonic acid on plasma lipoprotein distributions, apoproteins, blood lipid levels, and tissue fatty acid composition in humans. Lipids. 1997, 32:427-433.
41. Holub B.J. Docosahexaenoic acid (DHA) and cardiovascular disease risk factors. Prostaglandins Leukot Essent Fatty Acids 2009, 81:199-204.
42. Lee J.H., O'Keefe J.H., Lavie C.J., Marchioli R., Harris W.S. Omega-3 fatty acids for cardioprotection. Mayo Clin Proc 2008, 83:324-332.
43. Pedersen J.I., Ringstad J., Almendingen K., Haugen T.S., Stensvold I., Thelle D.S. Adipose tissue fatty acids and risk of myocardial infarction-a case-control study. Eur J Clin Nutr 2000, 54:618-625.
44. Clifton P., Keogh J., Noakes M. Trans fatty acids in adipose tissue and the food supply are associated with myocardial infarction. J Nutr 2004, 134:874-879.
45. Fuhrman B., Barba M., Krogh V., Micheli A., Pala V., Lauria R., et al. Erythrocyte membrane phospholipid composition as a biomarker of dietary fat. Ann Nutr Metab 2006, 50:95-102.
46. Lemaitre R., King I., Sotoodehnia N., Knopp R., Mozaffarian D., McKnight B., et al. Endogenous red blood cell membrane fatty acids and sudden cardiac arrest. Metabolism 2010, 59:1029-1034.
47. Forsythe C.E., Phinney S.D., Fernandez M.L., Quann E.E., Wood R.J., Bibus D.M., et al. Comparison of low fat and low carbohydrate diets on circulating fatty acid composition and markers of inflammation. Lipids 2008, 43:65-77.
48. Volek J.S., Fernandez M.L., Feinman R.D., Phinney S.D. Dietary carbohydrate restriction induces a unique metabolic state positively affecting atherogenic dyslipidemia, fatty acid partitioning, and metabolic syndrome. Prog Lipid Res 2008, 47:307-318.
49. Lustig R. Fructose: metabolic, hedonic, and societal parallels with ethanol. J Am Diet Assoc 2010, 110:1307-1321.
50. De Filippo C., Cavalieri D., Di Paola M., Ramazzotti M., Poullet J.B., Massart S., et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A 2010, 107:14691-14696.
51. Macia L., Thorburn A., Binge L., Marino E., Rogers K., Maslowski K., et al. Microbial influences on epithelial integrity and immune function as a basis for inflammatory diseases. Immunol Rev 2012, 245:164-176.
52. Mani V., Hollis J., Gabler N. Dietary oil composition differentially modulates intestinal endotoxin transport and postprandial endotoxemia. Nutr Metab 2013, 10:6.
53. Moreira A.P.B., Texeira T.F.S., Ferreira A., Peluzio Mdo C., Alfenas Rde C. Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia. Br J Nutr 2012, 108:801-809.
54. Lee J.Y., Zhao L., Youn H.S., Weatherill A.R., Tapping R., Feng L., et al. Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1. J Biol Chem 2004, 279:16971-16979.
55. Pal D. Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat Med 2012, 18:1279-1285.
56. Heinrichsdorff J., Olefsky J. Fetuin-A: the missing link in lipid-induced inflammation. Nat Med 2012, 18:1182-1183.
57. Straub R.H., Cutolo M., Buttgereit F., Pongratz G. Energy regulation and neuroendocrine-immune control in chronic inflammatory diseases. J Intern Med 2010, 267:543-560.
58. Straub R.H. Concepts of evolutionary medicine and energy regulation contribute to the etiology of systemic chronic inflammatory diseases. Brain Behav Immun 2011, 25:1-5.
59. Murch O., Collin M., Hinds C.J., Thiemermann C. Lipoproteins in inflammation and sepsis I. Basic science. Intensive Care Med 2007, 33:13-24.
60. Wendel M., Paul R., Heller A.R. Lipoproteins in inflammation and sepsis II. Clinical aspects. Intensive Care Med 2007, 33:25-35.
61. Levels J.H.M., Lemaire L.C.J.M., van den Ende A.E., van Deventer S.J.H., van Lanschot J.J.B. Lipid composition and lipopolysaccharide binding capacity of lipoproteins in plasma and lymph of patients with systemic inflammatory response syndrome and multiple organ failure. Crit Care Med 2003, 31:1647-1653.
62. Hudgins L.C., Parker T.S., Levine D.M., Gordon B.R., Saal S.D., Jiang X., et al. A single intravenous dose of endotoxin rapidly alters serum lipoproteins and lipid transfer proteins in normal volunteers. J Lipid Res 2003, 44:1489-1498.
63. Otocka Kmiecik A., Mikhailidis D., Nicholls S., Davidson M., Rysz J., Banach M. Dysfunctional HDL: a novel important diagnostic and therapeutic target in cardiovascular disease?. Prog Lipid Res 2012, 51:314-324.
64. Smith J.D. Dysfunctional HDL, as a diagnostic and therapeutic target. Arterioscler Thromb Vasc Biol 2010, 30:151-155.
65. Reaven G.M. The insulin resistance syndrome: definition and dietary approaches to treatment. Annu Rev Nutr 2005, 25:391-406.
66. Chavez J., Summers S. A ceramide-centric view of insulin resistance. Cell Metab 2012, 15:585-594.
67. Wong S.W., Kwon M., Choi A.M.K., Kim H., Nakahira K., Hwang D.H. Fatty acids modulate toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner. J Biol Chem 2009, 284:27384-27392.
68. Takeuchi H., Sekine S., Kojima K., Aoyama T. The application of medium-chain fatty acids: edible oil with a suppressing effect on body fat accumulation. Asia Pac J Clin Nutr 2008, 17(Suppl 1):320-323.
69. Muñoz A., Costa M. Nutritionally mediated oxidative stress and inflammation. Oxidative Medicine Cellular Longevity 2013, 610950.
70. Mayer K., Schaefer M.B., Seeger W. Fish oil in the critically ill: from experimental to clinical data. Curr Opin Clin Nutr Metab Care 2006, 9:140-148.
71. Calder P. Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?. Br J Clin Pharmacol 2012, 75:645-662.
72. Im D.S. Omega-3 fatty acids in anti-inflammation (pro-resolution) and GPCRs. Prog Lipid Res 2012, 51:232-237.
73. Alcock J., Franklin M., Kuzawa C. Nutrient signaling: evolutionary origins of the immune-modulating effects of dietary fat. Q Rev Biol 2012, 87:187-223.
74. Deopurkar R., Ghanim H., Friedman J., Abuaysheh S., Sia C., Mohanty P., et al. Differential effects of cream, glucose, and orange juice on inflammation, endotoxin, and the expression of Toll-like receptor-4 and suppressor of cytokine signaling-3. Diabetes Care 2010, 33:991-997.
75. Cani P., Amar J., Iglesias M., Poggi M., Knauf C., Bastelica D., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56:1761-1772.
76. Erridge C., Attina T., Spickett C.M., Webb D.J. A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr November 2007, 86:1286-1292.
77. Cani P.D., Delzenne N.M. The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des 2009, 15:1546-1558.
78. Mann G.V., Spoerry A., Gray M., Jarashow D. Atherosclerosis in the Masai. Am J Epidemiol 1972, 95:26-37.
79. Lindeberg S. Palaeolithic diet ("stone age" diet). Available at: . Date accessed: 12 Nov. 2012. Food & Nutrition Research 2005, 49.